MindRove

MindRove operates across neurotechnology, biosignal research tools, wearable hardware, and manufacturing. Its product range addresses several measurement areas: EEG for brain activity, EMG for muscle activity, and ECG for heart signals. Listed devices include EEG headsets with four- or six-channel configurations, EMG armband and legband sensors, and a Syncbox for coordinating data collection from up to four MindRove biosensors. The website materials also describe raw signal access, visualization, recording, filtering, software development kits, and real-time data interfaces. MindRove is listed as a private company with a pre-seed funding classification and a team-size band of one to ten employees. Its stated focus on research and application development suggests a specialist position serving developers and researchers who need access to biosignals across multiple sensing modalities.

MindRove was founded in 2017 and has a recorded pre-seed round dated Nov 22, 2018: €15,000, or $17,104 in the structured funding total, with Hiventures identified as an investor. A separate signal reports a €500,000 grant dated Apr 29, 2025 and names XR2Industry; because the structured total does not include that grant, the two funding figures should not be treated as reconciled. The product lineup spans EEG headsets, EMG wearables, a Syncbox, and motion-sensing hardware, while the website materials describe SDKs and real-time data tools. The company is categorized as active and its employee band is one to ten. Hiring information describes a commitment to diverse, bias-free recruitment, but does not identify roles, hiring volume, or a specific expansion plan.